Literature DB >> 26468058

Diffusion tensor imaging of the hippocampus predicts the risk of dementia; the RUN DMC study.

I W M van Uden1, A M Tuladhar1, H M van der Holst1, E M C van Leijsen1, A G W van Norden2, K F de Laat3, L C A Rutten-Jacobs4, D G Norris5,6, J A H R Claassen7, E J van Dijk1, R P C Kessels7,8, F-E de Leeuw1.   

Abstract

INTRODUCTION: Cerebral small vessel disease is one of the most important risk factors for dementia, and has been related to hippocampal atrophy, which is among the first observed changes on conventional MRI in patients with dementia. However, these volumetric changes might be preceded by loss of microstructural integrity of the hippocampus for which conventional MRI is not sensitive enough. Therefore, we investigated the relation between the hippocampal diffusion parameters and the risk of incident dementia, using diffusion tensor imaging, independent of hippocampal volume.
METHODS: The RUNDMC study is a prospective study among 503 elderly with small vessel disease, without dementia, with 5 years follow-up in 2012 (99.6% response-rate). Cox regression analysis was performed to calculate hazard ratios for dementia, of fractional anisotropy and mean diffusivity within the hippocampus, adjusted for demographics, hippocampal volume, and white matter. This was repeated in participants without evident hippocampal volume loss, because in these participants the visible damage might not yet have already started, whereas damage might have started on a microstructural level.
RESULTS: 43 participants developed dementia (8.6%), resulting in a 5.5-year cumulative risk of 11.1% (95%CI 7.7-14.6). Higher mean diffusivity was associated with an increased 5-year risk of dementia. In the subgroup of participants with the upper half hippocampal volume, higher hippocampal mean diffusivity, more than doubled the 5-year risk of dementia.
CONCLUSION: This is the first prospective study showing a relation between a higher baseline hippocampal mean diffusivity and the risk of incident dementia in elderly with small vessel disease at 5-year follow-up, independent of hippocampal volume and white matter volume.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebral small vessel disease; dementia; diffusion tensor imaging; elderly; hippocampus; imaging; magnetic resonance imaging

Mesh:

Year:  2015        PMID: 26468058      PMCID: PMC6867248          DOI: 10.1002/hbm.23029

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  45 in total

1.  Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study.

Authors:  J C de Groot; F E de Leeuw; M Oudkerk; J van Gijn; A Hofman; J Jolles; M M Breteler
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

2.  White matter integrity and depressive symptoms in cerebral small vessel disease: The RUN DMC study.

Authors:  Ingeborg W M van Uden; Anil M Tuladhar; Karlijn F de Laat; Anouk G W van Norden; David G Norris; Ewoud J van Dijk; Indira Tendolkar; Frank-Erik de Leeuw
Journal:  Am J Geriatr Psychiatry       Date:  2014-07-19       Impact factor: 4.105

3.  User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability.

Authors:  Paul A Yushkevich; Joseph Piven; Heather Cody Hazlett; Rachel Gimpel Smith; Sean Ho; James C Gee; Guido Gerig
Journal:  Neuroimage       Date:  2006-03-20       Impact factor: 6.556

4.  Diffusion tensor imaging of the hippocampus and verbal memory performance: the RUN DMC study.

Authors:  Anouk G W van Norden; Karlijn F de Laat; Ilma Fick; Inge W M van Uden; Lucas J B van Oudheusden; Rob A R Gons; David G Norris; Marcel P Zwiers; Roy P C Kessels; Frank-Erik de Leeuw
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

5.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

6.  Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

7.  Hippocampal mean diffusivity and memory in healthy elderly individuals: a cross-sectional study.

Authors:  Giovanni A Carlesimo; Andrea Cherubini; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Neurology       Date:  2010-01-06       Impact factor: 9.910

8.  Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus.

Authors:  Andreas Fellgiebel; Paulo R Dellani; Dirk Greverus; Armin Scheurich; Peter Stoeter; Matthias J Müller
Journal:  Psychiatry Res       Date:  2006-03-10       Impact factor: 3.222

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

Review 10.  Worldwide prevalence and incidence of dementia.

Authors:  L Fratiglioni; D De Ronchi; H Agüero-Torres
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 4.271

View more
  7 in total

Review 1.  Review of diffusion MRI studies in chronic white matter diseases.

Authors:  Rajikha Raja; Gary Rosenberg; Arvind Caprihan
Journal:  Neurosci Lett       Date:  2018-12-06       Impact factor: 3.046

2.  Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.

Authors:  Esther M C van Leijsen; Ingeborg W M van Uden; Mohsen Ghafoorian; Mayra I Bergkamp; Valerie Lohner; Eline C M Kooijmans; Helena M van der Holst; Anil M Tuladhar; David G Norris; Ewoud J van Dijk; Loes C A Rutten-Jacobs; Bram Platel; Catharina J M Klijn; Frank-Erik de Leeuw
Journal:  Neurology       Date:  2017-09-06       Impact factor: 9.910

3.  Using DTI to assess white matter microstructure in cerebral small vessel disease (SVD) in multicentre studies.

Authors:  Iain D Croall; Valerie Lohner; Barry Moynihan; Usman Khan; Ahamad Hassan; John T O'Brien; Robin G Morris; Daniel J Tozer; Victoria C Cambridge; Kirsty Harkness; David J Werring; Andrew M Blamire; Gary A Ford; Thomas R Barrick; Hugh S Markus
Journal:  Clin Sci (Lond)       Date:  2017-06-07       Impact factor: 6.124

4.  Apathy is associated with large-scale white matter network disruption in small vessel disease.

Authors:  Jonathan Tay; Anil M Tuladhar; Matthew J Hollocks; Rebecca L Brookes; Daniel J Tozer; Thomas R Barrick; Masud Husain; Frank-Erik de Leeuw; Hugh S Markus
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910

5.  Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.

Authors:  Esther M C van Leijsen; Ingeborg W M van Uden; Mayra I Bergkamp; Helena M van der Holst; David G Norris; Jurgen A H R Claassen; Roy P C Kessels; Frank-Erik de Leeuw; Anil M Tuladhar
Journal:  Neuroimage Clin       Date:  2019-10-22       Impact factor: 4.881

6.  Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease.

Authors:  Marco Egle; Saima Hilal; Anil M Tuladhar; Lukas Pirpamer; Steven Bell; Edith Hofer; Marco Duering; James Wason; Robin G Morris; Martin Dichgans; Reinhold Schmidt; Daniel J Tozer; Thomas R Barrick; Christopher Chen; Frank-Erik de Leeuw; Hugh S Markus
Journal:  Neuroimage Clin       Date:  2022-07-13       Impact factor: 4.891

Review 7.  Secondary prevention of Alzheimer's dementia: neuroimaging contributions.

Authors:  Mara Ten Kate; Silvia Ingala; Adam J Schwarz; Nick C Fox; Gaël Chételat; Bart N M van Berckel; Michael Ewers; Christopher Foley; Juan Domingo Gispert; Derek Hill; Michael C Irizarry; Adriaan A Lammertsma; José Luis Molinuevo; Craig Ritchie; Philip Scheltens; Mark E Schmidt; Pieter Jelle Visser; Adam Waldman; Joanna Wardlaw; Sven Haller; Frederik Barkhof
Journal:  Alzheimers Res Ther       Date:  2018-10-30       Impact factor: 6.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.